Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer

被引：0
|
作者：
Tímea Tőkés
Kornélia Kajáry
Gyöngyvér Szentmártoni
Zsolt Lengyel
Tamás Györke
László Torgyík
Krisztián Somlai
Anna-Mária Tőkés
Janina Kulka
Magdolna Dank
机构：
[1] Semmelweis University,Oncological Division, 1st Department of Internal Medicine
[2] Pozitron PET/CT Center,Department of Nuclear Medicine
[3] Semmelweis University,MTA
[4] Scanomed Ltd,SE Tumor Progression Research Group
[5] Surgical Division of the St Margaret Hospital,2nd Department of Pathology
[6] 2nd Department of Pathology,undefined
[7] Semmelweis University,undefined
来源：
Breast Cancer | 2017年 / 24卷
关键词：
Breast cancer; Primary systemic therapy; FDG-PET/CT; PERCIST; RECIST;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：137 / 146
页数：9
相关论文
共 50 条
  • [21] Comparison of prognostic value of different metabolic response criteria determined by PET/CT in patients with metastatic breast cancer under CDK 4/6 inhibitor treatment
    Onner, H.
    Erena, O. O.
    Koreza, M. K.
    Yilmaza, F.
    Gedika, G. K.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 318 - 323
  • [22] Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
    Riedl, Christopher C.
    Pinker, Katja
    Ulaner, Gary A.
    Ong, Leonard T.
    Baltzer, Pascal
    Jochelson, Maxine S.
    McArthur, Heather L.
    Gonen, Mithat
    Dickler, Maura
    Weber, Wolfgang A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1428 - 1437
  • [23] Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
    Christopher C. Riedl
    Katja Pinker
    Gary A. Ulaner
    Leonard T. Ong
    Pascal Baltzer
    Maxine S. Jochelson
    Heather L. McArthur
    Mithat Gönen
    Maura Dickler
    Wolfgang A. Weber
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1428 - 1437
  • [24] Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations
    Kajary, Kornelia
    Lengyel, Zsolt
    Tokes, Anna-Maria
    Kulka, Janina
    Dank, Magdolna
    Tokes, Timea
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 997 - 1006
  • [25] FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST
    Depardon, Edouard
    Kanoun, Salim
    Humbert, Olivier
    Bertaut, Aurelie
    Riedinger, Jean-Marc
    Tal, Ilan
    Vrigneaud, Jean-Marc
    Lasserre, Maud
    Toubeau, Michel
    Berriolo-Riedinger, Alina
    Dygai-Cochet, Inna
    Fumoleau, Pierre
    Brunotte, Francois
    Cochet, Alexandre
    PLOS ONE, 2018, 13 (07):
  • [26] 18FDG PET/CT imaging in primary breast lymphoma and breast cancer
    Estrada, Gisela
    Javier Ochoa-Carrillo, Francisco
    Altamirano, Javier
    CIRUGIA Y CIRUJANOS, 2008, 76 (04): : 273 - 280
  • [27] CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
    Skougaard, Kristin
    Johannesen, Helle Hjorth
    Nielsen, Dorte
    Schou, Jakob Vasehus
    Jensen, Benny Vittrup
    Hogdall, Estrid V. S.
    Hendel, Helle Westergren
    CANCER MEDICINE, 2014, 3 (05): : 1294 - 1301
  • [28] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    Groheux, David
    Ulaner, Gary A.
    Hindie, Elif
    CLINICAL AND TRANSLATIONAL IMAGING, 2023, 11 (05) : 439 - 452
  • [29] Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma
    Mavi, Mehmet Emin
    Turan, Basak Soydas
    Salanci, Bilge Volkan
    Bozkurt, Murat Fani
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (05) : E395 - E396
  • [30] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    David Groheux
    Gary A. Ulaner
    Elif Hindie
    Clinical and Translational Imaging, 2023, 11 : 439 - 452
12345